The Child Health Advantage program has contracted with GlaxoSmithKline (GSK) for vaccines since 2001. GSK is a fortune 500 pharmaceutical company headquartered in the UK and with operations based in the US. GSK conducts research for both medicines and vaccines. GSK is a pharmaceutical industry leader, with an estimated seven percent of the world's pharmaceutical market.